White Papers
-
Transforming Regulatory Processes Through AI, ML, NLP, And RPAs
4/7/2025
Explore the rapidly evolving landscape of regulatory processes as they undergo a profound digital transformation, highlighting how emerging technologies are reshaping traditional regulatory frameworks.
-
Key AI Trial Insights From Regulators And Consultants
4/4/2025
AI’s transformative impact promises more efficient, cost-effective, and successful clinical trials across the pharmaceutical landscape.
-
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity
3/28/2025
The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
-
Remote Patient Monitoring Using Mobile Health Technology
3/28/2025
This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
3/27/2025
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Innovative FSP Solutions For Biopharma Growth And Transition
3/24/2025
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
Harnessing RWE For Effective External Control Arms In Clinical Trials
3/24/2025
Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.
-
Safeguarding Personal Data: Protecting PII
3/17/2025
Learn about a secure, patient-centric platform that enables individuals to participate in clinical trials and registries while maintaining lifelong access to their data.
-
Navigating The Evolving Landscape Of Immunotherapy in Oncology
3/17/2025
Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.
-
Pioneering Gene Therapy In Rare Diseases
3/17/2025
Overcoming barriers to gene therapy development requires continued innovation in manufacturing processes, harmonized regulatory approaches, and outcome-based pricing models.